Daly AF, Beckers A (2020) The epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am 49:347–355. https://doi.org/10.1016/j.ecl.2020.04.002

Article  PubMed  Google Scholar 

Melmed S (2020) Pituitary-Tumor Endocrinopathies. N Engl J Med 382:937–950. https://doi.org/10.1056/nejmra1810772

Article  CAS  PubMed  Google Scholar 

Aflorei ED, Korbonits M (2014) Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol 117:379–394. https://doi.org/10.1007/s11060-013-1354-5

Article  PubMed  Google Scholar 

Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377–382. https://doi.org/10.1111/J.1365-2265.2009.03667.X

Article  PubMed  Google Scholar 

Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol 33:6–26. https://doi.org/10.1007/S12022-022-09703-7

Article  CAS  PubMed  Google Scholar 

Langlois F, Lim DST, Varlamov E et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58:528–534. https://doi.org/10.1007/S12020-017-1447-6

Article  CAS  PubMed  Google Scholar 

George DH, Scheithauer BW, Kovacs K et al (2003) Crooke’s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 27:1330–1336. https://doi.org/10.1097/00000478-200310000-00005

Article  PubMed  Google Scholar 

Portovedo S, Neto LV, Soares P et al (2022) Aggressive nonfunctioning pituitary neuroendocrine tumors. Brain Tumor Pathol 39:183–199. https://doi.org/10.1007/S10014-022-00441-6

Article  PubMed  Google Scholar 

Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135. https://doi.org/10.1007/s00401-013-1084-y

Article  PubMed  Google Scholar 

Raverot G, Dantony E, Beauvy J et al (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102:3368–3374. https://doi.org/10.1210/jc.2017-00773

Article  PubMed  Google Scholar 

Lelotte J, Mourin A, Fomekong E et al (2018) Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. 178:237–246. https://doi.org/10.1530/EJE-17-0965

Asioli S, Righi A, Iommi M et al (2019) Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur J Endocrinol 180:127–134. https://doi.org/10.1530/EJE-18-0749

Article  CAS  PubMed  Google Scholar 

Sahakian N, Appay R, Resseguier N et al (2022) Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol 187:893–904. https://doi.org/10.1530/EJE-22-0812

Article  CAS  PubMed  Google Scholar 

Lenders NF, Earls PE, Wilkinson AC et al (2023) Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres. Eur J Endocrinol 189:106–114. https://doi.org/10.1093/EJENDO/LVAD079

Article  PubMed  Google Scholar 

Peixe C, Alexandre MI, Gomes AR et al (2023) Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese cohort of 129 patients from a tertiary pituitary center. Pituitary 26:352–363. https://doi.org/10.1007/S11102-023-01319-2

Article  PubMed  Google Scholar 

Guaraldi F, Zoli M, Righi A et al (2020) A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s. Clin Endocrinol (Oxf) 93:36–43. https://doi.org/10.1111/cen.14197

Article  CAS  PubMed  Google Scholar 

Bonneville J-FF (2016) Magnetic resonance imaging of Pituitary tumors. Front Horm Res 45:97–120. https://doi.org/10.1159/000442327

Article  PubMed  Google Scholar 

Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–618. https://doi.org/10.1227/00006123-199310000-00008

Article  CAS  PubMed  Google Scholar 

Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9:847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Article  PubMed  PubMed Central  Google Scholar 

Zhang K, Shou X, Chen H et al (2021) Clinical parameters of Silent Corticotroph Adenomas with positive and negative adrenocorticotropic hormone immunostaining: a large retrospective single-center study of 105 cases. Front Endocrinol (Lausanne) 11. https://doi.org/10.3389/FENDO.2020.608691

Ioachimescu AG, Eiland L, Chhabra VS et al (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71:296–303. https://doi.org/10.1227/NEU.0B013E318257C1F0

Article  PubMed  Google Scholar 

Jahangiri A, Wagner JR, Pekmezci M et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73:8–17. https://doi.org/10.1227/01.NEU.0000429858.96652.1E

Article  PubMed  Google Scholar 

Castellnou S, Vasiljevic A, Lapras V et al (2020) SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors. Endocr Connect 9:243–253. https://doi.org/10.1530/EC-20-0035

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lüdecke DK, Buchfelder M, Fahlbusch R et al (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary Tumor Registry. Eur J Endocrinol 156:203–216. https://doi.org/10.1530/EJE.1.02326

Article  PubMed  Google Scholar 

Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg 135:1706–1713. https://doi.org/10.3171/2020.10.JNS203236

Article  CAS  PubMed  Google Scholar 

Langlois F, Lim DST, Yedinak CG et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21:32–40. https://doi.org/10.1007/S11102-017-0844-4

Article  CAS  PubMed  Google Scholar 

Vuong HG, Dunn IF (2023) The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis. Endocrine 82:527–535. https://doi.org/10.1007/S12020-023-03449-W

Article  CAS  PubMed  Google Scholar 

Goyal-Honavar A, Sarkar S, Asha HS et al (2021) A clinicoradiological analysis of silent corticotroph adenomas after the introduction of pituitary-specific transcription factors. Acta Neurochir (Wien) 163:3143–3154. https://doi.org/10.1007/S00701-021-04911-2

Article  PubMed  Google Scholar 

Jiang S, Zhu J, Feng M et al (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564–573. https://doi.org/10.1007/S11102-021-01133-8

Article  CAS  PubMed  Google Scholar 

Cazabat L, Dupuy M, Boulin A et al (2014) Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol (Oxf) 81:566–572. https://doi.org/10.1111/CEN.12443

Article  CAS  PubMed  Google Scholar 

Kasuki L, Antunes X, Coelho MCA et al (2020) Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol (Oxf) 92:145–149. https://doi.org/10.1111/CEN.14133